Petrova Penka 4
4 · Trillium Therapeutics Inc. · Filed Mar 12, 2021
Insider Transaction Report
Form 4
Petrova Penka
Chief Development Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-10−2,708→ 86,668 totalExercise: $0.30Exp: 2029-11-07→ Common Shares (2,708 underlying) - Exercise/Conversion
Common Shares
2021-03-10$0.30/sh+2,708$816→ 2,708 total - Exercise/Conversion
Common Shares
2021-03-10$3.35/sh+2,604$8,730→ 5,312 total - Sale
Common Shares
2021-03-10$11.08/sh−5,312$58,857→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-10−2,604→ 52,084 totalExercise: $3.35Exp: 2028-11-08→ Common Shares (2,604 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7925 USD.
- [F3]The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7925 USD.
- [F4]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.